Skip to main content
Toggle navigation
FR
EN
Drupal
Main navigation EN
About Crossject
Who we are
Governance
R&D
Our technology
ZENEO®: needle-free technology
Products under development
Our supply chain
Therapeutic areas
Epileptic seizure
Acute adrenal crisis
Anaphylactic shock
Severe asthma crisis
Migraines and cluster headaches
Opioid overdose
Rheumatoid arthritis
Main navigation 2 EN
Finances
Profile
Analyst coverage
Financial releases
News
Our news
Press releases
Careers
Working at Crossject
Contact
Search
Search
Enter the terms you wish to search for.
Home
Finances
Crossject signs a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense (DOD)
Crossject signs a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense (DOD)
Image
Date de parution
2019/10/14
PDF du document
2019_06 _CROSSJECT_ signs a Coorperative Research and Development Agreement with the US Departement of Defense.pdf
93.45 KB